F Arnold

Summary

Affiliation: University of Louisville
Country: USA

Publications

  1. ncbi Macrolides versus quinolones in Legionella pneumonia: results from the Community-Acquired Pneumonia Organization international study
    A T Griffin
    Department of Medicine, School of Medicine, University of Louisville, Louisville, Kentucky 40202, USA
    Int J Tuberc Lung Dis 14:495-9. 2010
  2. ncbi Predictive accuracy of the pneumonia severity index vs CRB-65 for time to clinical stability: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study
    Forest W Arnold
    University of Louisville, School of Medicine, Department of Medicine, Division of Infectious Diseases, Louisville, KY 40202, USA
    Respir Med 104:1736-43. 2010
  3. ncbi Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results
    Forest W Arnold
    Division of Infectious Diseases, Department of Medicine, School of Medicine, University of Louisville, 627 Preston St, Ste 100, Louisville, KY 40202, USA
    Arch Intern Med 169:1515-24. 2009
  4. ncbi Establishing a hospital program to improve antimicrobial use, control bacterial resistance and contain healthcare costs: the University of Louisville experience
    Forest W Arnold
    Division of Infectious Diseases, Department of Medicine, University of Louisville, KY 40202, USA
    J Ky Med Assoc 105:431-7. 2007
  5. ncbi A worldwide perspective of atypical pathogens in community-acquired pneumonia
    Forest W Arnold
    Division of Infectious Diseases, University of Louisville, Louisville, KY 40292, USA
    Am J Respir Crit Care Med 175:1086-93. 2007
  6. ncbi The pneumonia severity index predicts time to clinical stability in patients with community-acquired pneumonia
    F Arnold
    Division of Infectious Diseases, University of Louisville, Louisville, Kentucky 40292, USA
    Int J Tuberc Lung Dis 10:739-43. 2006
  7. ncbi Improving antimicrobial use in the hospital setting by providing usage feedback to prescribing physicians
    Forest W Arnold
    Division of Infectious Diseases, Department of Medicine, School of Medicine, University of Louisville, 512 South Hancock Street, Louisville, KY 40292, USA
    Infect Control Hosp Epidemiol 27:378-82. 2006
  8. ncbi An analysis of a community-acquired pathogen in a Kentucky community: methicillin-resistant Staphylococcus aureus
    Forest W Arnold
    University of Louisville School of Medicine, KY 40292, USA
    J Ky Med Assoc 103:206-10. 2005
  9. ncbi Improving antimicrobial use: longitudinal assessment of an antimicrobial team including a clinical pharmacist
    Forest W Arnold
    University of Louisville, Dept of Medicine, Division of Infections Diseases, 512 S Hancock St, Carmichael Bldg, Rm 208E, Louisville, KY 40292, USA
    J Manag Care Pharm 10:152-8. 2004
  10. ncbi Clinical outcomes of HIV-infected patients hospitalized with bacterial community-acquired pneumonia
    Maricar Malinis
    Division of Infectious Disease, University of Louisville School of Medicine, Louisville, KY, USA
    Int J Infect Dis 14:e22-7. 2010

Detail Information

Publications12

  1. ncbi Macrolides versus quinolones in Legionella pneumonia: results from the Community-Acquired Pneumonia Organization international study
    A T Griffin
    Department of Medicine, School of Medicine, University of Louisville, Louisville, Kentucky 40202, USA
    Int J Tuberc Lung Dis 14:495-9. 2010
    ..Data supporting a quinolone or a macrolide as preferred therapy for community-acquired pneumonia (CAP) due to Legionella pneumophila are not firmly established. Some literature suggests a benefit of quinolones over macrolides...
  2. ncbi Predictive accuracy of the pneumonia severity index vs CRB-65 for time to clinical stability: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study
    Forest W Arnold
    University of Louisville, School of Medicine, Department of Medicine, Division of Infectious Diseases, Louisville, KY 40202, USA
    Respir Med 104:1736-43. 2010
    ..It is unknown how well either score predicts time to clinical stability in hospitalized patients with CAP. Thus, it is also not known which score predicts time to clinical stability better...
  3. ncbi Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results
    Forest W Arnold
    Division of Infectious Diseases, Department of Medicine, School of Medicine, University of Louisville, 627 Preston St, Ste 100, Louisville, KY 40202, USA
    Arch Intern Med 169:1515-24. 2009
    ....
  4. ncbi Establishing a hospital program to improve antimicrobial use, control bacterial resistance and contain healthcare costs: the University of Louisville experience
    Forest W Arnold
    Division of Infectious Diseases, Department of Medicine, University of Louisville, KY 40202, USA
    J Ky Med Assoc 105:431-7. 2007
    ....
  5. ncbi A worldwide perspective of atypical pathogens in community-acquired pneumonia
    Forest W Arnold
    Division of Infectious Diseases, University of Louisville, Louisville, KY 40292, USA
    Am J Respir Crit Care Med 175:1086-93. 2007
    ..In different regions of the world, monotherapy with a beta-lactam antimicrobial is common...
  6. ncbi The pneumonia severity index predicts time to clinical stability in patients with community-acquired pneumonia
    F Arnold
    Division of Infectious Diseases, University of Louisville, Louisville, Kentucky 40292, USA
    Int J Tuberc Lung Dis 10:739-43. 2006
    ..A total of 33 hospitals in 13 countries in North America, Europe, Africa, Asia and Latin America...
  7. ncbi Improving antimicrobial use in the hospital setting by providing usage feedback to prescribing physicians
    Forest W Arnold
    Division of Infectious Diseases, Department of Medicine, School of Medicine, University of Louisville, 512 South Hancock Street, Louisville, KY 40292, USA
    Infect Control Hosp Epidemiol 27:378-82. 2006
    ..To determine whether feedback on antimicrobial use improves physician compliance with local hospital guidelines on antimicrobial prescribing...
  8. ncbi An analysis of a community-acquired pathogen in a Kentucky community: methicillin-resistant Staphylococcus aureus
    Forest W Arnold
    University of Louisville School of Medicine, KY 40292, USA
    J Ky Med Assoc 103:206-10. 2005
    ..Reviewing risk factors in adult patients with CA-MRSA in Kentucky has not been reported...
  9. ncbi Improving antimicrobial use: longitudinal assessment of an antimicrobial team including a clinical pharmacist
    Forest W Arnold
    University of Louisville, Dept of Medicine, Division of Infections Diseases, 512 S Hancock St, Carmichael Bldg, Rm 208E, Louisville, KY 40292, USA
    J Manag Care Pharm 10:152-8. 2004
    ....
  10. ncbi Clinical outcomes of HIV-infected patients hospitalized with bacterial community-acquired pneumonia
    Maricar Malinis
    Division of Infectious Disease, University of Louisville School of Medicine, Louisville, KY, USA
    Int J Infect Dis 14:e22-7. 2010
    ..There are limited and conflicting data on clinical outcomes of community-acquired pneumonia (CAP) among HIV-infected patients...
  11. ncbi Hospitalization for community-acquired pneumonia: the pneumonia severity index vs clinical judgment
    Forest W Arnold
    Division of Infectious Diseases, Department of Medicine, University of Louisville, Louisville, KY, USA
    Chest 124:121-4. 2003
    ..According to our study, the pneumonia severity index should not be used as the sole indicator with which to define inappropriate hospitalization...
  12. ncbi Obtaining routine blood cultures during interleukin-2-containing therapy is unnecessary
    Michael V Jaglal
    Department of Medicine, University of Louisville, Louisville, KY 40202, USA
    Am J Clin Oncol 32:429-31. 2009
    ..To evaluate the usefulness of routine blood cultures in patients who develop temperatures of 38.5 degrees C or higher while treated with interleukin-2 (IL-2)...